참고문헌
- Hoy D, Bain C, Williams G, et al. A systematic review of the global prevalence of low back pain. Arthritis Rheum. 2012;64:2028-37. https://doi.org/10.1002/art.34347
- Podichetty VK, Mazanec DJ, Biscup RS. Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J. 2003;79:627-33. https://doi.org/10.1136/pmj.79.937.627
- Tauben D. Nonopioid medications for pain. Phys Med Rehabil Clin N Am. 2015;26:219-48. https://doi.org/10.1016/j.pmr.2015.01.005
- Attal N, Cruccu G, Baron R, et al.; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-23,e67-88. https://doi.org/10.1111/j.1468-1331.2010.02999.x
- Kieffer BL. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell Mol Neurobiol. 1995;15:615-35. https://doi.org/10.1007/BF02071128
- Megale RZ, Deveza LA, Blyth FM, et al. Efficacy and safety of oral and transdermal opioid analgesics for musculoskeletal pain in older adults: a systematic review of randomized, placebo-controlled trials. J Pain. 2018;19:475.e1-475.e24. https://doi.org/10.1016/j.jpain.2017.12.001
- Pasternak GW. Opioids and their receptors: are we there yet? Neuropharmacology. 2014;76 Pt B:198-203. https://doi.org/10.1016/j.neuropharm.2013.03.039
- Carnide N, Hogg-Johnson S, Cote P, et al. Early prescription opioid use for musculoskeletal disorders and work outcomes: a systematic review of the literature. Clin J Pain. 2017;33:647-58. https://doi.org/10.1097/AJP.0000000000000452
- Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet. 1993;342:321-4. https://doi.org/10.1016/0140-6736(93)91471-W
- Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest. 1996;98:793-9. https://doi.org/10.1172/JCI118852
- Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol. 2001;28:2176-83.
- Spetea M. Opioid receptors and their ligands in the musculoskeletal system and relevance for pain control. Curr Pharm Des. 2013;19:7382-90. https://doi.org/10.2174/13816128113199990363
- Chou R, Fanciullo GJ, Fine PG, et al.; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-30. https://doi.org/10.1016/j.jpain.2008.10.008
- Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129:355-62. https://doi.org/10.1016/j.pain.2007.02.014
- Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573-82. https://doi.org/10.1016/j.jpain.2007.02.432
- Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46. https://doi.org/10.1186/1472-6963-6-46
- Kastelic N, Farless H, Pericak A. Guidelines for the chronic use of opioid analgesics [Internet]. Euless (TX): The Federation of State Medical Boards; 2017 Apr [updated 2017 Aug 10; cited 2019 Jan 15]. Available from: http://sciencepolicy.duke.edu/content/guidelines-chronic-use-opioid-analgesics-model-policy.
- Hwang IC, Shim JY. Opioids use for chronic noncancer pain. J Korean Med Assoc. 2013;56:711-7. https://doi.org/10.5124/jkma.2013.56.8.711
- Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94. https://doi.org/10.1503/cmaj.051528
- Lee YW. Opioid therapy for chronic nonmaliganat pain. Hanyang Med Rev. 2011;31:70-5. https://doi.org/10.7599/hmr.2011.31.2.70
- Obata H. Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci. 2017;18:E2483. https://doi.org/10.3390/ijms18112483
- Barakat A, Hamdy MM, Elbadr MM. Uses of fluoxetine in nociceptive pain management: a literature overview. Eur J Pharmacol. 2018;829:12-25. https://doi.org/10.1016/j.ejphar.2018.03.042
- Onutu AH. Duloxetine, an antidepressant with analgesic properties - a preliminary analysis. Rom J Anaesth Intensive Care. 2015;22:123-8.
- Beal BR, Wallace MS. An overview of pharmacologic management of chronic pain. Med Clin North Am. 2016;100:65-79. https://doi.org/10.1016/j.mcna.2015.08.006
- Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Dtsch Arztebl Int. 2016;113:616-25.
- Shah S, Kapoor S, Durkin B. Analgesic management of acute pain in the opioid-tolerant patient. Curr Opin Anaesthesiol. 2015;28:398-402. https://doi.org/10.1097/ACO.0000000000000218
- Acikalin A, Satar S, Avc A, Topal M, Kuvandk G, Sebe A. QTc intervals in drug poisoning patients with tricyclic antidepressants and selective serotonin reuptake inhibitors. Am J Ther. 2010;17:30-3. https://doi.org/10.1097/MJT.0b013e318197eec6
- Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Ann Pharmacother. 2014;48:1620-8. https://doi.org/10.1177/1060028014550645
- Beach SR, Kostis WJ, Celano CM, et al. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014;75:e441-9. https://doi.org/10.4088/JCP.13r08672